2006Unpublished venueRequires access

Immunophenotypic characteristics of multiple myeloma

Ruan Chang-gen

Open publisher page 0 citations

Abstract

Objective The main objective of this work was to investigate the immunophenotypic characteristics of mutiple myeloma. Methods We have examined the co-expression of CD19, CD20, CD34,CD13, CD38, CD45, CD56 and CD138 in marrow aspirates in 6 normal peoples and 55 patients with MM by flow cytometry. The analysis was based on at least 3×104 events. Results The percentage of MM cells ranged between 3.8 % and 63.2 % in 55 bone marrow aspirates of MM. The presence of CD138, CD38, CD56, CD20, CD19, CD13 and CD33 was expressed in 100 %, 100 %, 81.8 %, 20.0 %, 3.6 %, 10.9 % and 21.8 % respectively. The cells were negative or dim for CD45 antigens. The others were negative. Conclusion The immunophenotyping analysis of MM is a useful tool for diagnosis, further evaluating prognosis and detection of residual after treatment.

About this research paper

What this paper is about

Objective The main objective of this work was to investigate the immunophenotypic characteristics of mutiple myeloma. Methods We have examined the co-expression of CD19, CD20, CD34,CD13, CD38, CD45, CD56 and CD138 in marrow aspirates in 6 normal peoples and 55 patients with MM by flow cytometry. The analysis was based on at least 3×104 events. Results The percentage of MM cells ranged between 3.8 % and 63.2 % in 55 bone marrow aspirates of MM. The presence of CD138, CD38, CD56, CD20, CD19, CD13 and CD33 was expressed in 100 %, 100 %, 81.8 %, 20.0 %, 3.6 %, 10.9 % and 21.8 % respectively. The cells were negative or dim for CD45 antigens. The others were negative. Conclusion The immunophenotyping analysis of MM is a useful tool for diagnosis, further evaluating prognosis and detection of residual after treatment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective The main objective of this work was to investigate the immunophenotypic characteristics of mutiple myeloma. Methods We have examined the co-expression of CD19, CD20, CD34,CD13, CD38, CD45, CD56 and CD138 in marrow aspirates in 6 normal peoples and 55 patients with MM by flow cytometry. The analysis was based on at least 3×104 events. Results The percentage of MM cells ranged between 3.8 % and 63.2 % in 55 bone marrow aspirates of MM. The presence of CD138, CD38, CD56, CD20, CD19, CD13 and CD33 was expressed in 100 %, 100 %, 81.8 %, 20.0 %, 3.6 %, 10.9 % and 21.8 % respectively. The cells were negative or dim for CD45 antigens. The others were negative. Conclusion The immunophenotyping analysis of MM is a useful tool for diagnosis, further evaluating prognosis and detection of residual after treatment.

Key concepts: Immunophenotyping, CD20, CD34, Bone marrow, CD38, CD19, Multiple myeloma, Flow cytometry

Related papers

Back to paper searchBrowse research topicsOriginal source
Immunophenotypic characteristics of multiple myeloma — Research Paper | ScholarLens